Profusa Competitors
| PFSA Stock | 0.09 0.01 6.41% |
Profusa Common vs Biocardia Correlation
Weak diversification
The correlation between Profusa Common Stock and BCDA is 0.32 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Profusa Common Stock and BCDA in the same portfolio, assuming nothing else is changed.
Moving together with Profusa Stock
| 0.79 | GLH | Global Health | PairCorr |
| 0.78 | DOCS | Doximity Earnings Call Today | PairCorr |
| 0.84 | VSEE | VSee Health | PairCorr |
Moving against Profusa Stock
| 0.86 | BIMT | Bitmis Corp | PairCorr |
| 0.85 | ALMDT | Mediantechn | PairCorr |
| 0.77 | ONE | Oneview Healthcare Plc | PairCorr |
| 0.71 | ENS | Enersys Earnings Call This Week | PairCorr |
| 0.69 | FCTI | Fact Inc | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Profusa Common's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Profusa Common Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Profusa Common and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Profusa and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Profusa Common Stock does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Profusa Stock performing well and Profusa Common Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Profusa Common's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CHEK | 9.87 | 3.24 | 0.41 | (0.56) | 6.07 | 17.16 | 198.26 | |||
| ACXP | 4.44 | (1.22) | 0.00 | (0.65) | 0.00 | 10.84 | 49.19 | |||
| LUCY | 4.81 | (0.57) | 0.00 | (0.25) | 0.00 | 9.70 | 57.39 | |||
| SBFM | 2.12 | (0.60) | 0.00 | (0.40) | 0.00 | 4.13 | 13.93 | |||
| HCWB | 4.99 | (1.55) | 0.00 | 1.29 | 0.00 | 13.02 | 41.72 | |||
| BFRI | 3.64 | (0.26) | 0.00 | (0.04) | 0.00 | 6.76 | 34.13 | |||
| ADIL | 2.83 | (0.76) | 0.00 | (0.79) | 0.00 | 4.55 | 16.67 | |||
| GBS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| APRE | 3.82 | (1.06) | 0.00 | (0.58) | 0.00 | 4.40 | 46.26 | |||
| BCDA | 2.58 | (0.24) | 0.00 | (0.13) | 0.00 | 5.93 | 21.46 |
Cross Equities Net Income Analysis
Compare Profusa Common Stock and related stocks such as Check Cap, Acurx Pharmaceuticals LLC, and Innovative Eyewear Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACXP | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (5.9 M) | (4.6 M) | (12.7 M) | (12.1 M) | (14.6 M) | (14.1 M) | (12.7 M) | (13.3 M) |
| LUCY | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (109.4 K) | (768.2 K) | (3.2 M) | (5.7 M) | (6.7 M) | (7.8 M) | (7 M) | (6.6 M) |
| SBFM | (13.1 K) | (556.2 K) | (708 K) | (2.5 M) | (1.9 M) | (1.7 M) | (3.5 M) | (1 M) | (2.2 M) | (1.7 M) | (2.8 M) | (12.4 M) | (26.7 M) | (4.5 M) | (5.1 M) | (4.6 M) | (4.9 M) |
| HCWB | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (7.3 M) | (5.8 M) | (12.9 M) | (14.9 M) | (25 M) | (30 M) | (27 M) | (25.7 M) |
| BFRI | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (37.7 M) | (640 K) | (20.1 M) | (17.8 M) | (16 M) | (16.8 M) |
| ADIL | (818 K) | (818 K) | (818 K) | (818 K) | (818 K) | (818 K) | (420.2 K) | (1.1 M) | (11.6 M) | (8.6 M) | (10.9 M) | (19.4 M) | (12.7 M) | (7 M) | (13.2 M) | (11.9 M) | (12.5 M) |
| APRE | (3.5 M) | (254 K) | (254 K) | (436.2 K) | (15.2 M) | (15.2 M) | (15.2 M) | (15.2 M) | (15.5 M) | (28.1 M) | (53.9 M) | (36.5 M) | (112.7 M) | (14.3 M) | (13 M) | (11.7 M) | (12.2 M) |
| BCDA | 135.6 K | 9.7 M | 305 K | 19 K | 234 K | 322 K | (10.3 M) | (12.3 M) | (14 M) | (14.7 M) | (15 M) | (12.6 M) | (11.9 M) | (11.6 M) | (7.9 M) | (7.2 M) | (6.8 M) |
Profusa Common Stock and related stocks such as Check Cap, Acurx Pharmaceuticals LLC, and Innovative Eyewear Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Profusa Common Stock financial statement analysis. It represents the amount of money remaining after all of Profusa Common Stock operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Profusa Common Competitive Analysis
The better you understand Profusa Common competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Profusa Common's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Profusa Common's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Profusa Common Competition Performance Charts
Five steps to successful analysis of Profusa Common Competition
Profusa Common's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Profusa Common Stock in relation to its competition. Profusa Common's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Profusa Common in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Profusa Common's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Profusa Common Stock, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Profusa Common position
In addition to having Profusa Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Macroaxis Picks Thematic Idea Now
Macroaxis Picks
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Profusa Common Correlation with its peers. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profusa Common. Anticipated expansion of Profusa directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Profusa Common assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Profusa Common Stock using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profusa Common's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Profusa Common's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profusa Common's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profusa Common should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profusa Common's market price signifies the transaction level at which participants voluntarily complete trades.